Content uploaded by Bartosz Kulczyński
Author content
All content in this area was uploaded by Bartosz Kulczyński on Mar 03, 2016
Content may be subject to copyright.
Pol. J.Food Nutr. Sci., 2016, Vol. 66, No. 2, pp. 0–0
DOI: 10.1515/pjfns-2015-0040
http://journal.pan.olsztyn.pl
Review article
Section: Nutritional Research
© Copyright by Institute of Animal Reproduction and Food Research of the Polish Academy of Sciences
© 2016 Author(s). This is an open access article licensed under the Creative Commons Attribution-NonCommercial-NoDerivs License
(http://creativecommons.org/licenses/by-nc-nd/3.0/).
INTRODUCTION
The rapid increase in diseases of prosperity has led to
more intensifi ed research into substances contributing to
their prevention and treatment. Results ofmany investiga-
tions showed that life style changes, such as awell-balanced
diet and physical exercise, may effectively prevent the oc-
currence ofmany diseases [Amagase & Farnsworth, 2011;
Amani & Gill, 2013; Batcagan-Abueg etal., 2013; Gramza-
-Michałowska et al., 2011; Gramza-Michałowska, 2014;
Marrazzo et al., 2014; Shashirakha et al., 2015]. Based on
thecurrent analysis of food, as well as clinical and epide-
miological research, scientists are searching for products
characterized by better health-promoting properties. Raw
materials that can be used for the production of properly
engineered food are also being investigated [Ahmad et al.,
2015; Hęś etal., 2011; Kmiecik etal., 2015]. Bioactive food
isan emerging fi eld inthecontext ofhealth andnutrition.
Many people andassociations have defi ned its importance.
However, the American Dietetic Association (ADA) has
proposed the most accurate defi nition of the bioactive in-
gredients of food: “Bioactive food components are physi-
ologically active constituents infoods or dietary supplements
derived from both animal andplant sources, including those
needed to meet basic human nutrition needs, that have been
demonstrated to have arole inhealth andto besafe for hu-
man consumption” [Saldanha, 2004]. Carotenoids, fl avo-
noids, isofl avones, phytoestrogens, sterols, stanols, vitamins
andchemical elements, fi ber, fatty acids, probiotics andpre-
biotics as well as bioactive peptides are constituents ofbioac-
* Corresponding Author: Tel.: +4861 8487331, Fax: +4861 8487430
E-mail: bartosz.kulczynski@up.poznan.pl (B.Kulczyński)
tive food [Guine etal., 2010; Milner, 2004; Hęś etal., 2011;
Reguła & Gramza-Michałowska, 2013; Sharma & Singh,
2010]. Research showed that bioactive compounds offood
origin may fulfi ll many health-promoting functions inthehu-
man organism [Astrup etal., 2010; Castro etal., 2005; Cho
et al., 2013; Kris-Etherton etal., 2002; Liu, 2013; Meydani
& Hasan, 2010; Moller etal., 2008; Morimoto et al., 2012;
Reguła & Gramza-Michałowska, 2010; Srinath & Katan,
2004]. They may lower cholesterol levels andblood pressure,
enhance theimmune system, regulate blood glucose levels
andhormonal balance, help inthereduction ofweight, slow
down theageing processes andcounteract cancer.
ORIGIN ANDDESCRIPTION OFGOJI FRUITS
Goji produces an ellipsoid orange-red berry approxi-
mately 2 cm deep with a sweet-and-tangy fl avor. The Goji
berry isthefruit ofL. barbarum and
L. chinense inthefamily
Solanaceae that ranges from tomato andpotato to eggplant.
Theauthor ofthespecies name, L. barbarum, was Carl Lin-
naeus in1753, whereas L. chinese was named 15years later
byPhilip Miller. Itisalso known as Chinese wolfberry, pos-
sibly because Chinese farmers observed wolves eating these
berries. L. barbarum andL. chinense are native to Asia, pri-
marily inthecentral north region called Ningxia Hui Autono-
mous Region. Inaddition, commercial volumes ofwolfberries
grow intheChinese regions ofXinjiang, Shaanxi, Gansu, He-
bei, Inner Mongolia, andalso inJapan, Korea, andTaiwan.
China, the main supplier of wolfberry, yields 95,000 tones
ofGoji fruits, derived from 82,000hectares. Goji berries have
been an important part oftraditional Chinese medicine for
more than 2000 years due to their rich chemical composi-
tion andmedical properties. As afood, dried wolfberries are
traditionally cooked before consumption, used as herbal tea,
Goji Berry (Lycium barbarum): Composition andHealth Effects – aReview
Bartosz Kulczyński*, Anna Gramza-Michałowska
Faculty ofFood Science andNutrition, Poznań University ofLife Sciences, Wojska Polskiego 31, 60–624Poznań, Poland
Key words: goji berries, Lycium barbarum, bioactive compounds, antioxidants, polyphenols, health benefi ts
Goji berries contain many nutrients andbioactive compounds which allowed to classify them as superfruits. Ashort description ofthefruits ispre-
sented together with cultivation requirements. Thechemical composition oftheberries andtheir health-promoting properties are described later inthis
literature review. Based on theavailable data, their potentially benefi cial application indietary prevention ofdiseases ofaffl uence, such as diabetes,
cardiovascular diseases andcancer, iselaborated. We also refer to thesafety ofGoji consumption inthecontext ofingredients potentially harmful for
human health, allergic reactions andtheinteractions with other substances.
0 Goji Berries inNutrition
as well as in Chinese soups, or in combination with meat
andvegetarian meals. Goji fruits are also used for thepro-
duction ofjuice, wine andtincture [Gross, 2006; Amagase &
Farnsworth, 2011; Benzie & Wachtel-Galor, 2011; Potterat,
2010]. Goji isaplant introduced to Europe inthe18th cen-
tury [Sopher, 2013]. L. barbarum prefers well-drained slightly
alkaline soils [Peaceful Valley Farm Supply, 2013], andsunny
locations. Germination temperature is21–23°C, whereas for
L. barbarum this is15–25°C andisresistant to low tempera-
tures, fi rst fruition however istypically observed in3-year-old
plants [Dominion Seed House, 2013; Marczyński & Pio-
trowski, 2013].
CHEMICAL COMPOSITION OFGOJI BERRY
Goji berries are not without reason termed a“superfruit”.
Wolfberries contain many nutrients with high biological activ-
ity, such as polysaccharide complexes, carotenoids, phenyl-
propanoids andothers, as characterized below. Thepolysac-
charide complex isthemost important andthemost abundant
group ofcompounds present inGoji fruits. They are present
in the water-soluble form of highly branched L. barbarum
Polysaccharides (LBP) with amolecular weight of8–214kDa,
and comprise 5–8% of the
total dry matter of the fruits.
Their composition includes six types of monosaccharides:
arabinose, rhamnose, xylose, mannose, galactose, glucose,
galacturonic acid and eighteen amino acids [Amagase &
Farnsworth, 2011]. Research ofdos Reis etal. [2014] showed
that goji berries fermentation yielded 87% sugars decrease
within 24h, without losses inpolyphenol content, however
carotenoid content was reduced by17%. Carotenoids pres-
ent inGoji are thesecond highly signifi cant group ofbiolog-
ically-active constituents with health promoting properties.
They are responsible for thecharacteristic orange-red color
of the berries. They comprise 0.03–0.5% of the dry matter
ofthefruits (Table 1). Zeaxanthin isone ofthemost common
carotenoids present inGoji (31–56% ofthetotal carotenoid
pool). Itispresent intheform ofdipalmitin zeaxanthin. Goji
isconsidered thebest natural source ofdipalmitin zeaxanthin
known so far. Beta-carotene, neoxanthin, cryptoxanthin are
also present at lower concentrations [Peng etal., 2005; Wang
etal., 2010]. Phenylpropanoids are bioactive compounds with
avery high antioxidant capacity. Analysis oftheantioxidant
activity and phenylpropanoids in different medicinal Chi-
nese herbs has confi rmed thepresence ofthese constituents
inGoji berry at thelevel of22.7mg (gallic acid equivalent/g
extract) [Guo et al., 2008]. A comparison of the phenolic
profi le andvitamin C content ofGoji berry fruit ispresented
inTable2. Wang etal. [2010] isolated andmeasured thelev-
els ofindividual fl avonoid fractions. Themost common were
quercetin-3-O-rutinoside, kaempferol-3-O-rutinoside, chlo-
rogenic acid, caffeic acids andsmall amounts ofcaffeoylquin-
ic acid andp-coumaric acid [Zhong etal. 2013]. Goji berries
contain 1.0–2.7% offree amino acids, with themost abun-
dant being proline. Thepresence oftaurine andbetaine has
also been confi rmed [Potterat, 2010]. Additional compounds
present inGoji fruits are: vitamins, such as thiamin, ribofl a-
vin, andascorbic acid with its glucosidic precursor (2-O-β-D-
-glucopyranosyl). Theconcentration ofvitamin C was found
at 42mg/100g [Donno et al., 2015]. Llorent-Martínez etal.
[2013] confi rmed the presence of many mineral elements,
themost common ofwhich were potassium (1460mg/100g),
sodium (550mg/100g), phosphorus (184mg/100g), magne-
sium (90g/100g) andcalcium (50mg/100g). Interestingly,
theiron concentration of5.5mg/100g ishigh inrespect to Di-
etary Reference Intake (DRI). Goji also contains organic ac-
ids, such as citric acid, malic acid, fumaric acid andshikimic
acid [Mikulic-Petkovsek etal., 2012]. Themost common fatty
acids are: palmitic acid, linoleic acid andmyristic acid. Ac-
cording to literature, Goji berries provide 370kcal/100g dried
fruits [Gross, 2006].
HEALTH-PROMOTING PROPERTIES OF GOJI
BERRIES
Hypoglycemic properties
Many experiments have been performed inorder to un-
derstand how Goji acts on the way the body handles car-
bohydrates. Luo et al. [2004] have investigated thecorrela-
tion between supplementation with different polysaccharide
fractions of Goji fruit and the levels of glucose in blood.
Theeffects ofL. barbarum preparations inalloxan-induced
diabetic rabbits have been investigated bymeasuring ablood
glucose level. Decreased blood glucose levels (3.9mmol/L)
were recognized as substantial hypoglycemic effects. Results
oftheexperiment were unambiguous. Itwas found that all
Goji preparations resulted in signifi cantly decreased blood
glucose levels after 10days oftreatment inthetested animals,
indicating that there was asubstantial hypoglycemic effect.
Moreover, thehypoglycemic effect ofpurifi ed polysaccharide
fractions was more signifi cant than those ofwater decoction
andcrude polysaccharide fractions, implying that L. barbarum
polysaccharides were major bioactive components inthehy-
poglycemic effect. Guowen etal. [2010] performed asimilar
experiment andthe
results were propitious. Mice treated with
L. barbarum extracts were characterized bysignifi cantly re-
duced blood glucose levels compared to thediabetic control
group. Many experiments confi rm diabetes iscorrelated with
high oxidative stress. Hyperglycemia–induced oxidative stress
TABLE 1. Composition ofbioactive carotenoid fractions ingoji berries
(Lycium barbarum).
Compound
References
Wang etal. [2010] Inbaraj etal. [2008]
Carotenoid
fractions
13- or 13’-cis-β-carotene
(8.97mg/g), all-trans-
-β-carotene (16.6mg/g),
9- or 9’-cis-β-carotene
(10.3mg/g), neoxanthin
(13.2mg/g), all-trans-β-
cryptoxanthin (53.3mg/g),
9- or 9’-cis-β-
-cryptoxanthin (5.61mg/g),
9- or 9’-cis-zeaxanthin
(39.3mg/g), 13- or 13’-cis-
zeaxanthin (4.85mg/g),
15- or 15’–cis-zeaxanthin
(32.8mg/g), all-trans-
zeaxanthin (1326mg/g)
all-trans-zeaxanthin
(1.4μg/g), all-trans-β-
-carotene (23.7μg/g),
zeaxanthin monopalmitate
(11,3–62.8μg/g),
β-cryptoxanthin
monopalmitate
(32.9–68.5μg/g),
zeaxanthin dipalmitate
(1143.7μg/g)
B.Kulczyński & A.Gramza-Michałowska 0
may beimplied indiabetes onset. Theeffect ofL. barbarum
treatment on antioxidative protective mechanisms has been
investigated in streptomycin-induced diabetic rat kidneys.
Theantioxidative activity ofsuperoxide dismutase, catalase
andglutathione was signifi cantly increased after Goji poly-
saccharide fractions treatment. Moreover, free radical scav-
enging activity was also elevated [Li, 2007]. Another experi-
ment confi rmed theincreased activity ofantioxidant enzymes
in kidneys, lungs and liver of polysaccharide fractions-fed
mice. Moreover, thesame experiment revealed that animals
on high-fat diets supplemented with polysaccharide fractions
had statistically lower levels ofglucose, compared to mice on
high-fat diets only [Ming etal., 2009].
LIPID-LOWERING PROPERTIES INBLOOD
Theeffect ofpolysaccharide fractions supplemented high-
fat diet has been analyzed inmice inorder to evaluate its im-
pact on total cholesterol, its LDL andHDL fractions andtri-
glyceride levels. Mice administered polysaccharide fractions
supplemented high-fat diets were characterized bydecreased
concentrations oftotal cholesterol, LDL-cholesterol andtri-
glycerides and increased HDL-cholesterol concentrations
compared to mice on high-fat diets without polysaccharide
fractions [Li, 2007]. Cui et al. [2011] obtained identical re-
sults. Pai et al. [2013] performed similar experiments with
rats on high-fat diets. Two groups of animals were tested,
acontrol group (normal diet) andagroup on high-fat diets
supplemented with hypoglycemic drug-statin (Atorvastatin).
The results are consistent with previous
fi ndings. Polysac-
charide fractions supplementation caused adecrease intotal
cholesterol, LDL-cholesterol fraction and triglyceride con-
centration compared to therats on thecontrol high-fat diet.
Moreover, the polysaccharide fractions-supplemented rats
were characterized bystatistically lower triglyceride andsta-
tistically higher HDL-cholesterol concentrations compared to
theatorvastatin-treated rats [Pai etal., 2013]. Guowen etal.
[2010] performed an alternative analysis where the effect
ofthepolysaccharide fractions supplementation on thedia-
betic mice lipid profi le was evaluated. Thegroup ofanimals
supplemented with Goji extract had signifi cantly lower con-
centrations oftriglycerides andtotal cholesterol compared to
thediabetic control group. Zhao etal. [2005] obtained simi-
lar results confi rming thehypothesis that Goji polysaccharide
fractions supplementation has apositive effect on the lipid
profi le of rats through decreasing total cholesterol and tri-
glyceride concentrations. Luo et al. [2004] performed an
experiment with alloxan-induced diabetic rabbits andfound
that polysaccharide fractions supplementation resulted
inahypolipemic effect andasimultaneous increase in
HDL-
-cholesterol concentrations. Then, Cheng etal. [2011] investi-
gated changes inthelipid profi le ofpolysaccharide fractions-
supplemented rats with alcohol defects oftheliver andfound
much lower levels oftriglycerides, total cholesterol andLDL-
-cholesterol fraction, andasimultaneously increased HDL-
-cholesterol concentration.
TABLE 2. Phenolic profi le andvitamin C content ofGoji berry (Lycium barbarum) fruit.
Chemical compound
(mg/100g fw)
Donno etal. [2015]
(mg/g ext)
Wang etal. [2010]
(μg/g pm)
Mocan etal. [2014]
Cinnamic acids Caffeic acid 110.84 3.73 < 0.02
Chlorogenic acid 113.18 12.40 5899.29
Coumaric acid 111.32 6.06 30.29
Ferulic acid 125.80 n.e. < 0.02
Flavonols Hyperoside 116.27 n.e. n.e.
Isoquercitrin n.d. n.e. < 0.02
Quercetin n.d. n.e. 5.59
Quercetin-diglycoside – 66.00 n.e.
Quercitrin n.d. n.e. 13.00
Rutin n.d. 42.00 5646.66
Kaempferol-3-O-rutinoside – 11.30 n.d.
Benzoic acids Ellagic acid n.d. n.e. n.e.
Gallic acid 15.31 n.e. n.e.
Catechins Catechin 118.76 n.e. n.e.
Epicatechin 229.18 n.e. n.e.
Ellagitannins Castalagin n.d. n.e. n.e.
Vescalagin n.d. n.e. n.e.
Vitamin Vitamin C 48.94
fw – fresh weight; ext – extract; pm – plant material; n.d. – not detected; n.e. – not evaluated
0 Goji Berries inNutrition
IMMUNOSTIMULATORY AND ANTICANCER
ACTIVITY
Traditional Chinese medicine has utilized compounds pres-
ent inGoji fruits to prevent theonset andprogression ofcancer.
Goji also exhibits immunostimulatory activity. Ithas been con-
fi rmed inmany tests that compounds present inGoji berries
have pro-apoptotic andantiproliferative activity against cancer
cells [Tang etal., 2012]. Gan etal. [2004] confi rmed that Goji
polysaccharide fractions could signifi cantly inhibit thegrowth
oftransplantable sarcoma inmice, moreover increased mac-
rophage phagocytosis andantibody secretion byspleen cells.
Furthermore, spleen lymphocyte proliferation was enhanced
in comparison with the affl icted control group. It was also
found that Goji polysaccharide fractions could signifi cantly
reduce lipid peroxidation in mice and inhibit proliferation
ofliver cancer cells [Zhang etal., 2005]. Mao etal. [2011] also
showed theanticancer properties ofpolysaccharide fractions.
They proved theanticancer effect ofL. barbarum polysaccha-
rides on colon cancer cells through G0/G1phase arrest. Zhu
& Zhang [2013] also confi rmed the antiproliferative activity
of
Goji polysaccharide fractions against HeLa cells, probably
through induction ofapoptosis. Zhang et al. [2011a,b] also
observed asimilar effect. They found that theanticancer effect
ofGoji berry was attributed to 2-O-(beta-D-glucopyranosyl)
ascorbic acid. Goji fruits are also asource ofscopoletin. Ithas
been proven that scopoletin induces inhibition ofhuman pros-
tate cancer cell proliferation (PC-3) [Liu etal., 2000]. Amagase
with cooworkers [2009b] investigated theeffect ofGoji juice
on healthy Chinese adults. Lymphocyte, interleukin- 2 (IL-2)
andimmunoglobulin G levels inthetreated group were signifi -
cantly higher than those intheplacebo group. Gan etal. [2003]
observed activation oftheimmune system components through
the administration of a L. barbarum polysaccharide-protein
complex that increased theexpression ofinterleukin-2andtu-
mor necrosis factor-alpha at both mRNA and protein lev-
els in human peripheral blood mononuclear cells. Glycans
andglycoconjugates present inGoji exert astimulatory effect
on theexpression ofNF-κB (nuclear factor kappa-light-chain-
enhancer ofactivated B cells) andtheactivator protein 1(AP-1)
[Peng et al., 2001]. Chen et al. [2008] confi rmed activation
NF-κB andAP-1through L. barbarum polysaccharides. They
claimed that isolated fractions ofLBP affected theproliferation
ofT cells andenhanced production ofInterleukin 2andInter-
feron gamma (IFNγ).
PROTECTIVE PROPERTY OF GOJI ON RETINA
CELLS
Aprotective property ofGoji extracts on retina cells has
been proved intheearly stage ofthedegeneration ofthereti-
na. Itis
proposed that absorbing thelight zeaxanthin andlu-
teolin present in Goji fruit displays an inhibitory effect on
neuron apoptosis [Ni etal., 2013]. Yu etal. [2013] proved that
bioactive compounds present inL. barbarum enhance theex-
pression of zeaxanthin and luteolin genes in diabetic mice.
Itispostulated that inhibited expression ofthese genes can
cause hyperglycemia. Thus, Goji berries display neuroprotec-
tive properties on adiabetic animal’s retina. Theneuroprotec-
tive effect ofpolysaccharide fractions on theretinal ganglion
cells (RGC) inrats with high intraocular pressure (IOP) also
contributes to theprevention ofglaucoma [Chiu etal., 2010].
Tang et al. [2011] and Hu et al. [2012] also confi rmed its
protective infl uence on diabetic retinal injury. Theprotective
property ofL. barbarum extract on human retina neuron cells
has also been demonstrated [Shen etal., 2012]. Itissuggested
that Goji extract containing taurine may inhibit theprogress
ofdiabetic retinopathy [Song etal., 2011].
FIGURE 1. ORAC values for antioxidant activity ofdifferent fruits
ORAC – Oxygen Radical Absorbance Capacity; H-ORAC – hydrophilic for water soluble antioxidants ORAC value; L-ORAC – lipophilic for lipid
soluble antioxidants ORAC value; TE – Trolox equivalents; compilation ofresults [USDA, 2010].
Orange
Grapefruit
Raspberries
Blueberry
Blackberry
Apple
Plum
Goji berry
Fruit
0 1000 2000 3000 4000 5000 6000
ORAC (μmol TE/100g)
TOTAL-ORAC L-ORAC H-ORAC
B.Kulczyński & A.Gramza-Michałowska 0
ANTIOXIDANT POTENTIAL
Chemical analysis ofGoji berry confi rmed its high anti-
oxidative activity. Based on the current analysis it was con-
cluded that L. barbarum displays scavenging activity against
free radicals (superoxide anion, hydroxyl radicals). Goji anti-
oxidative activity ismainly attributed to carotenoid pigments,
fl avonoids, polysaccharide fraction and vitamin analog –
C-2-O-(beta-D-glucopyranosyl) ascorbic acid [Guo et al.,
2008; Jiang, 2014; Li & Zhou, 2007; Lin et al., 2009; Wang
et al., 2010; Zhang etal., 2011a,b]. One ofthewidely used
markers ofantioxidant potential isORAC value (TheOxygen
Radical Absorbance Capacity) [Gramza-Michałowska & Kor-
czak, 2013]. ORAC offresh berries was found to besimilar to
cherry or red currant [USDA, 2010]. Acomparison ofORAC
values for the antioxidant activity of goji berries and other
fruits ispresented in Figure 1. ORAC assay results for fruits
represent its antioxidant value, not proportionally however for
thehuman body, because ofthebioactive compounds absorp-
tion and metabolism. The effect of L. barbarum extract on
theoxidative stress induced inliver ofrats on high-fat diets
was investigated. Changes in
theliver tissue levels ofmalondi-
aldehyde (MDA), glutathione, as well as activity ofantioxidant
enzymes (superoxide dismutase, catalase andglutathione per-
oxidase) andoxygen radical absorbance capacity were used as
biomarkers oftheprotective effect ofL. barbarum used as adi-
etary supplement. Thedecreased MDA level used as amarker
oflipid peroxidation was observed inanimals on high-fat di-
ets supplemented with L. barbarum. Furthermore, increased
concentrations ofglutathione andantioxidant enzyme activi-
ties were evaluated [Cui etal., 2011]. Theprotective effect of
L.barbarum extract on rats with alcohol-induced liver necrosis
was investigated byCheng & Kong [2011]. Results showed
that animals supplemented with Goji fruits extract exhibited
decreased activity ofalanine aminotransferase (ALT) andas-
partate transaminase (AST), biomarkers of liver damage.
Moreover, adecreased MDA concentration andasignifi cant
increase inantioxidant enzyme activity SOD, CAT, GPx andin-
creased glutathione levels characterized rats supplemented
with L. barbarum extract. Shan etal. [2011] analyzed theinfl u-
ence ofGoji fruit polysaccharides on oxidative stress induced
by physical activity. The L. barbarum supplemented-group
was characterized bya
decreased MDA content andhigher
levels ofSOD andGPX, which confi rmed protection against
oxidative stress caused byphysical activity. Li etal. [2007] per-
formed an interesting experiment on mice supplemented with
polysaccharide fraction andanalyzed oxidative stress caused
by ageing. They observed increased activity of endogenous
antioxidant systems (SOD, CAT, GSH-Px), decreased levels
oflipid peroxidation markers (MDA) andincreased total anti-
oxidative capacity intheorgans ofanimals (lungs, liver, heart,
andbrain) supplemented with polysaccharide fraction ofGoji
berries [Li et al., 2007]. Then, Xiao et al. [2012] confi rmed
that this fraction exhibited liver-protective properties against
thehepatotoxic oxidative stress inducer carbon tetrachloride.
Reduced liver necrosis rates, increased activity ofendogenous
antioxidant system, anddecreased lipid peroxidation expressed
as MDA level were measured. Responses ofhumans supple-
mented with Goji juice exhibited similar patterns (increased
activity ofantioxidant enzymes SOD andGSH-Px, andde-
creased lipid peroxidation) [Amagase et al., 2009a; Bucheli
etal. 2011]. Wu etal. [2004] confi rmed thescavenging activity
against superoxide anions andinhibition oflipid peroxidation.
Huang et al. [2001] also proved theantioxidative properties
of L. barbarum. They showed that glycoconjugates present
inGoji berries inhibit peroxidation ofLDL-cholesterol frac-
tion. Goji berries antioxidant capacity parameters evaluated
with several methods were presented inTable 3.
SAFETY ISSUES
Wolfberries have attracted rapidly growing attention for
their documented nutrient value, which has led to aprofusion
ofconsumer products. Goji products can bebought inhealth
food stores inEurope andNorth America, andare advertised
as natural mood boosters with anti-ageing properties. There-
ported health-promoting biological effects of L. barbarum
indeed justify theterm “superfruit”. While Goji berries have
many health benefi ts, there are some side effects that consum-
ers need to beaware of(thepresence oftoxic substances, risk
ofallergies andinteractions with other medications).
The controversially high content of atropine (0.95%),
a
toxic alkaloid naturally present in Goji fruit, was tested
in berries from India in 1989. However, published case re-
ports do not describe people who have experienced atropine
poisoning [Harsh, 1989]. Adams etal. [2006] carefully tested
atropine levels bymeans ofHPLC-PAD andTLC methods.
They were not able to detect atropine. Using HPLC-MS,
asmall amount ofatropine was found, with amaximum con-
tent of19ppb, well below atoxic level.
Allergic reactions to Goji berries rarely occur and only
afew cases have been described. Monzón Ballarín etal. [2011]
described thefi rst two cases ofpatients who experienced al-
lergic symptoms after Goji berry consumption. First woman
developed anaphylaxis after eating Goji berries, accompanied
byacute generalized urticaria on thehands, palms andlips,
edema, dyspnea, andacute rhinitis; andsecond who reported
generalized urticaria, severe pruritus andskin lesions (hives),
TABLE 3. Goji antioxidant capacity parameters evaluated with several
methods.
Refer ences TEAC FRAP DPPH TPC
Henning etal.
[2014]
2.7
[mmol
TE/100g]
0.9
[mmol
TE/100g]
1.4
[mmol
TE/100g]
–
Mocan etal.
[2014]
35.72
[μg TE/mg]
–
29.30
[μg QE/mg]
6159
[mg GAE/g]
dos Reis etal.
[2014]
–––
16.67
[mg GAE/g]
Medina
[2011]
–––
895
[mg
GAE/100g]
Donno etal.
[2015]
–––
268.35
[mg
GAE/100g]
TEAC – Trolox Equivalent Antioxidant Capacity; FRAP – Ferric Reduc-
ing Antioxidant Potential; DPPH – 2,2’-diphenyl-1-picrylhydrazyl; TPC
– Total Polyphenol Content; QE – Quercetin equivalents; TE – Trolox
equivalents; GAE – Gallic Acid Equivalents
0 Goji Berries inNutrition
angioedema, and dysphagia after Goji berry consumption.
Theskin prick tests were positive for Goji berry. Additional
tests confi rmed an allergy to Goji berries inboth cases. Lipid
transfer proteins (LTPs) seem to beinvolved inallergic sensi-
tization to L. barbarum berries, andresults have demonstrated
ahigh degree ofcross-reactivity between Goji berry andpeach
andtomato [Carnes etal., 2013; Larramendi etal., 2012].
Three published case reports have described patients who
experienced interactions between Goji berry andwarfarin, an
anticoagulant drug. An elevated International Normalized
Ratio (INR) was observed inpatients after drinking Goji tea
and juice, previously stabilized on anticoagulation therapy,
also increased bleeding from rectum andnose was observed
[Lam etal., 2001; Leung etal., 2008; Rivera etal., 2012]. Pos-
sible interactions between Goji andprescription medications
are still unknown, thus therisks ofwolfberries should betaken
into consideration inindividuals who take medications with
anarrow therapeutic index.
CONCLUSIONS
Goji berry is well-known in traditional Chinese medicine
andhas been utilized as an important element ofahealth-pro-
moting diet for hundreds ofyears. Recently, there has been rap-
idly growing attention surrounding wolfberries inthe
Western
world. Health food stores provide arich variety ofGoji products,
such as dried fruits, tea, beer, juice, sweets, musli andsupple-
ments [Potterat, 2010]. L. barbarum isaplant that could becul-
tivated inEurope. Themain aim ofthis review was to gather
andpresent state oftheart data regarding thehealth-promoting
properties ofGoji fruits. Goji berry isasource ofmany bioactive
compounds, characterized byhigh antioxidant potential. Goji
fruits with awide spectrum ofbiological effects have numerous
implied health effects. Wolfberry may be an effective supple-
ment inprophylaxis ofdiseases ofaffl uence, such as diabetes,
cardiovascular diseases andcancer. Goji isasafe food supple-
ment, free from toxins; however, it can cause allergies; thus,
therisks should betaken into consideration inindividuals with
food allergies, due to thehigh degree ofcross-reactivity between
wolfberry andpeach andtomato. On thegrounds ofharmful
herb-drug interactions that enhance drug performance, an an-
ticoagulation therapy (warfarin) isacontra-indication to use
Goji berry and
any product containing wolfberry. Themajority
ofpublished studies have used animal models inexperiments.
Theresults have been very optimistic andpromising. However,
additional research must bedone with agreater number ofex-
periments involving alarger number ofanimals, as well as ex-
periments involving human subjects.
ACKNOWLEDGEMENTS
Financial support by the UE Project no. PO IG
01.01.02.00–061/09 “Bioactive Food” isgreatly appreciated.
REFERENCES
1. Adams M., Wiedenmann M., Tittel G., Bauer R., HPLC-MS
trace analysis ofatropine inLycium berries. Phytochem. Anal.,
2006, 17, 279–283.
2. Ahmad S.R., Gokulakrishnan P., Giriprasad R., Yatoo M.A.,
Fruit based natural antioxidants in meat and meat products:
areview. Crit. Rev. Food Sci. Nutr., 2015, 55, 1503–1513.
3. Amagase H., Farnsworth N.R., Areview ofbotanical characteris-
tics, phytochemistry, clinical relevance ineffi cacy andsafety ofLy-
cium barbarum fruit (Goji). Food Res. Int., 2011, 44, 1702–1717.
4. Amagase H., Sun B., Borek C., Lycium barbarum (goji) juice im-
proves invivo antioxidant biomarkers inserum ofhealthy adults.
Nutr. Res., 2009a, 29, 19–25.
5. Amagase H., Sun B., Nance D., Immunomodulatory effects
ofastandardized Lycium barbarum fruit juice inChinese older
healthy human subjects. J.Med. Food., 2009b, 12, 1159–1165.
6. Amani R., Gill T., Shiftworking, nutrition andobesity: implica-
tions for workforce health- asystematic review. Asia Pac. J.Clin.
Nutr., 2013, 22, 505–515.
7. Astrup A., Kristensen M., Gregersen N.T., Belza A., Lorenzen
J.K., Due A., Larsen T.M., Can bioactive foods affect obesity?
Ann. N.Y. Acad. Sci., 2010, 1190, 25–41.
8. Batcagan-Abueg A.P.M., Lee J.J.M., Chan P., Rebello S.A., Am-
arra M.S.V., Salt intakes andsalt reduction initiatives inSouth-
east Asia: areview. Asia Pac. J.Clin. Nutr., 2013, 22, 490–504.
9. Benzie I.F.F., Wachtel-Galor S., Herbal Medicine: Biomolecular
andClinical Aspects. 2011, 2nd ed. Boca Raton, FL: CRC Press.
10. Bucheli P., Vidal K., Shen L., Gu Z., Goji berry effects on macular
characteristics andplasma antioxidant levels. Optom. Vis. Sci.,
2011, 88, 257–262.
11. Carnés J., de Larramendi.CH., Ferrer A., Huertas A.J., López-
-Matas M.A., Pagán J.A., Peña M., Recently introduced foods
as new allergenic sources: sensitisation to Goji berries (Lycium
barbarum). Food Chem., 2013, 137, 130–135.
12. Castro I.A., Barroso L.P., Sinnecker P., Functional foods for cor-
onary heart disease risk reduction: ameta-analysis using amul-
tivariate approach. Am. J.Clin. Nutr., 2005, 82, 32–40.
13. Chen Z., Tan B.K.H., Chan S.H., Activation ofT lymphocytes
by polysaccharide-protein complex from Lycium barbarum
L.Int. Immunopharmacol., 2008, 8, 1663–1671.
14. Cheng D., Kong H., Theeffect ofLycium barbarum polysaccha-
ride on alcohol-induced oxidative stress inrats. Molecules, 2011,
16, 2542–2550.
15. Chiu K., Zhou Y., Yeung S.C., Lok C.K.M., Chan O.O.C.,
Chang R.C.C., Chiu J.F., Up-regulation ofcrystallins isinvolved
intheneuroprotective effect ofwolfberry on survival ofretinal
ganglion cells inrat ocular hypertension model. J.Cell Biochem.,
2010, 110, 311–320.
16. Cho Y.H., Ahn S.C., Lee S.Y., Jeong D.W., Choi E.J., Kim Y.J.,
Lee J.G., Lee Y.H., Shin B.C., Effect ofKorean red ginseng on
insulin sensitivity innon-diabetic healthy overweight andobese
adults. Asia Pac. J.Clin. Nutr., 2013, 22, 365–371.
17. Cui B., Liu S., Lin X., Wang J., Li S., Wang Q., Li S., Effects
ofLycium barbarum aqueous andethanol extracts on high-fat-
diet induced oxidative stress inrat liver tissue. Molecules, 2011,
16, 9116–9128.
18. Dominion Seed House [online]., GOJI (Lycium barbarum) [ac-
cess: 19–12–2013]. Retrieved from [http://www.dominion-seed-
house.com/upload/GOJI_AN.pdf].
19. Donno D., Beccaro G.L., Mellano M.G., Cerutti A.K., Bou-
nous G., Goji berry fruit (Lycium spp.): antioxidant compound
fi ngerprint and bioactivity evaluation. J. Funct. Food., 2015,
doi:10.1016/j.jff.2014.05.020.
B.Kulczyński & A.Gramza-Michałowska 0
20. dos Reis B.A., Kosińska–Cagnazzo A., Schmitt R., Andlauer W.,
Fermentation ofplant material – Effect on sugar content andsta-
bility ofbioactive compounds. Pol. J.Food Nutr. Sci., 2014, 64,
235–241.
21. Gan L., Zhang S.H., Liang Yang X., Bi Xu H., Immunomodu-
lation andantitumor activity byapolysaccharide-protein com-
plex from Lycium barbarum. Int. Immunopharmacol., 2004, 4,
563–569.
22. Gan L., Zhang S.H., Liu Q., Xu H.B., Apolysaccharide-protein
complex from Lycium barbarum upregulates cytokine expression
inhuman peripheral blood mononuclear cells. Eur. J.Pharma-
col., 2003, 471, 217–222.
23. Gramza-Michałowska A., Caffeine in tea Camellia sinensis –
content, absorption, benefi ts andrisks ofconsumption. J.Nutr.
Health Aging, 2014, 18, 143–149.
24. Gramza-Michałowska A., Korczak J., Oxygen radical absor-
bance capacity ofselected food products. Acta Sci. Pol., Technol.
Aliment., 2013, 12, 175–180.
25. Gramza-Michałowska A., Sidor A., Hęś M., Herb extract infl u-
ence on the oxidative stability of selected lipids. J. Food Bio-
chem., 2011, 35, 1723–1736.
26. Gross M.P., [online]., Exotic Antioxidant Superfruits. Volume 2:
Goji (“Wolfberry”) [access: 19–12–2013]. Retrieved from [http://
www.gojitrees.com/BerryDoctorGoji-GeneralEbook0–07.pdf].
27. Guiné R.P.F., Lima M.J.R., Barroca M.J., Functional compo-
nents ofFoods. 2010, in: Food, Diet andHealth. Past, Present
andFuture Tendencies (ed. R.P.F.Guiné). Nova Science Publish-
ers, New York, pp. 59–135.
28. Guo D.J., Cheng H.L., Chan S.W., Yu P.H.F., Antioxidative activ-
ities andthetotal phenolic contents oftonic Chinese medicinal
herbs. Infl ammopharmacology, 2008, 16, 201–207.
29. Guowen C., Longjun J., Qiang F., Anti-hyperglycemic activ-
ity of a polysaccharide fraction from Lycium barbarum. Afr.
J.Biomed. Res., 2010, 13, 55–59.
30. Harsh M.L., Tropane alkaloids from Lycium barbarum Linn.
invivo andinvitro. Curr. Sci., 1989, 58, 817–818.
31. Henning S.M., Zhang Y., Rontoyanni V.G., Huang J., Lee R.,
Trang A., Nuernberger G., Heber D., Variability intheantioxi-
dant activity of dietary supplements from pomegranate, milk
thistle, green tea, grape seed, goji, andacai: effects ofinvitro di-
gestion. J.Agric. Food Chem., 2014, 62, 4313−4321.
32. Hęś M., Jeżewska M., Szymandera–Buszka K., Gramza-
-Michałowska A., Effect ofantioxidant additives on nutritive val-
ue ofdried meat. Zyw. Nauka Technol. Jakosc., 2011, 5, 94–106.
33. Hu C.K., Lee Y.J., Colitz C.M., Chang C.J., Lin C.T., Theprotec-
tive effects ofLycium barbarum andChrysanthemum morifolum on
diabetic retinopathies inrats. Vet. Ophthalmol., 2012, 15, 65–71.
34. Huang L.J., Tian G.Y., Wang Z.F., Dong J.B., Wu M.P., Stud-
ies on theglycoconjugates andglycans from Lycium barbarum
L ininhibiting low density lipoprotein (LDL) peroxidation. Acta
Pharm. Sin., 2001, 36, 108–111.
35. Inbaraj B.S., Lu H., Hung C.F., Wu W.B., Lin C.L., Chen B.H.,
Determination of carotenoids and their esters in fruits of Ly-
cium barbarum Linnaeus byHPLC-DAD-APCI-MS.
J. Pharm.
Biomed. Anal., 2008, 47, 812–818.
36. Jiang L., Preparation and antioxidant activity of Lycium bar-
barum oligosaccharides. Carbohydr. Polym., 2014, 99, 646–648.
37. Kmiecik D., Korczak J., Rudzińska M., Gramza-Michałowska
A., Hęś M., Kobus-Cisowska J., Stabilization of phytosterols
bynatural andsynthetic antioxidants inhigh temperature condi-
tions. Food Chem., 2015, 173, 966–971.
38. Kris-Etherton P.M., Hecker K.D., Bonanome A., Coval S.M.,
Binkoski A.E., Hilpert K.F., Griel A.E., Etherton T.D., Bioactive
compounds infoods: their role intheprevention ofcardiovascu-
lar disease andcancer. Am. J.Med., 2002, 113, 71S–88S.
39. Lam A.Y., Elmer G.W., Mohutsky M.A., Possible interaction
between warfarin andLycium barbarum L.Ann. Pharmacother.,
2001, 35, 1199–1201.
40. Larramendi C.H., García-Abujeta J.L., Vicario S., García-Endri-
no A., López-Matas M.A., García-Sedeño M.D., Carnés J., Goji
berries (Lycium barbarum): risk ofallergic reactions inindividu-
als with food allergy. J.Investig. Allergol. Clin. Immunol., 2012,
22, 345–350.
41. Leung H., Hung A., Hui A.C.F., Chan T.Y.K., Warfarin overdose
due to thepossible effects ofLycium barbarum L.Food Chem.
Toxicol., 2008, 46, 1860–1862.
42. Li X., Ma Y., Liu X., Effect oftheLycium barbarum polysaccha-
rides on age-related oxidative stress inaged mice. J.Ethnophar-
macol., 2007, 111, 504–511.
43. Li X., Zhou A., Evaluation oftheantioxidant effects ofpolysac-
charides extracted from Lycium barbarum. Med. Chem. Res.,
2007, 15, 471–482.
44. Li X.M., Protective effect ofLycium barbarum polysaccharides
on streptozotocin-induced oxidative stress in
rats. Int. J. Biol.
Macromol., 2007, 40, 461–465.
45. Lin C., Wang C., Chang S., Antioxidative activity of polysac-
charide fractions isolated from Lycium barbarum Linnaeus. Int.
J.Biol. Macromol., 2009, 45, 146–151.
46. Liu R.H., Dietary bioactive compounds andtheir health implica-
tions. J.Food Sci., 2013, 78, A18–25.
47. Liu X.L., Sun J.Y., Li H.Y., Zhang L., Qian B.C., Extraction
andisolation ofactive component for inhibiting PC3cell prolif-
eration invitro from thefruit ofLycium barbarum L.J. Chinese
Materia Medica, 2000, 25, 481–483.
48. Llorent-Martínez E.J., Fernández-de Córdova M.L., Ortega-
-Barrales P., Ruiz-Medina A., Characterization andcomparison
ofthechemical composition ofexotic superfoods. Microchem.
J., 2013, 110, 444–451.
49. Luo Q., Cai Y., Yan J., Sun M., Corke H., Hypoglycemic andhy-
polipidemic effects andantioxidant activity offruit extracts from
Lycium barbarum. Life Sci., 2004, 76, 137–149.
50. Mao F., Xiao B., Jiang Z., Zhao J., Huang X., Guo J., Anticancer
effect ofLycium barbarum polysaccharides on colon cancer cells
involves G0/G1phase arrest. Med. Oncol., 2011, 28, 121–126.
51. Marczyński S., Piotrowski W., Clematis [online]. Encyclopae-
dia ofvines [access: 07–12–2013]. Retrieved from [http://www.
clematis.com.pl].
52. Marrazzo G., Barbagallo I., Galvano F., Malaguarnera M., Gaz-
zolo D., Frigiola A., D’Orazio N., Li Volti G., Role of dietary
andendogenous antioxidants in diabetes. Crit. Rev. Food Sci.
Nutr., 2014, 54, 1599–1616.
53. Medina M.B., Determination of the total phenolics in juices
and superfruits by a novel chemical method. J.
Funct. Foods,
2011, 3, 79–87.
54. Meydani M., Hasan S.T., Dietary polyphenols andobesity. Nu-
trients, 2010, 2, 737–751.
55. Mikulic-Petkovsek M., Schmitzer V., Slatnar A., Stampar F., Ve-
beric R., Composition ofsugars, organic acids, andtotal pheno-
0 Goji Berries inNutrition
lics in25wild or cultivated berry species. J.Food Sci., 2012, 77,
C1064–1070.
56. Milner J.A., Molecular targets for bioactive food components.
J.Nutr., 2004, 134, 2492S-2498.
57. Ming M., Guanhua L., Zhanhai Y., Guang C., Xuan Z., Ef-
fect oftheLycium barbarum polysaccharides administration on
blood lipid metabolism andoxidative stress ofmice fed high-fat
diet invivo. Food Chem., 2009, 113, 872–877.
58. Mocan A., Vlase L., Vodnar D.C., Bischin C., Hanganu D., Ghel-
diu A., Operan R., Silaghi-Dumitrescu R., Crisan G., Polyphe-
nolic content, antioxidant andantimicrobial activities ofLycium
barbarum L. andLycium chinense Mill. leaves. Molecules, 2014,
19, 10056–10073.
59. Möller N.P., Scholz-Ahrens K.E., Roos N., Schrezenmeir J., Bio-
active peptides andproteins from foods: indication for health ef-
fects. Eur. J.Nutr., 2008, 47, 171–182.
60. Monzón Ballarín S., López-Matas M.A., Sáenz Abad D., Pérez-
-Cinto N., Carnés J., Anaphylaxis associated with theingestion
ofGoji berries (Lycium barbarum). J.Investig. Allergol. Clin. Im-
munol., 2011, 21, 567–570.
61. Morimoto A., Ohno Y., Tatsumi Y., Mizuno S., Watanabe S.,
Effects ofhealthy dietary pattern andother lifestyle factors on
incidence ofdiabetes inarural Japanese population. Asia Pac.
J.Clin. Nutr., 2012, 21, 601–608.
62. Ni T., Wei G., Yin X., Liu X., Liu D., Neuroprotective effect ofLy-
cium barbarum on retina ofRoyal College ofSurgeons (RCS)
rats: apreliminary study. Folia Neuropathol., 2013, 2, 158–163.
63. Pai P., Habeeba P., Ullal S., Evaluation ofhypolipidemic effects
of Lycium barbarum (Goji Berry) in a murine model. J. Nat.
Rem., 2013, 13, 4–8.
64. Peaceful Valley Farm Supply [online]. Goji (Wolf) Berries. Plant-
ing and growing guide [access: 21–12–2013]. Retrieved from
[http://www.groworganic.com/media/pdfs/goji-l.pdf].
65. Peng X.M., Qi C.H., Tian G.Y., Zhang Y.X., Physico-chemical
properties andbioactivities ofaglycoconjugate LbGp5B from
Lycium barbarum L.Chin. J.Chem., 2001, 19, 842–846.
66. Peng Y., Ma C., Li Y., Leung K.S.Y., Jiang Z.H., Zhao Z., Quan-
tifi cation ofzeaxanthin dipalmitate andtotal carotenoids inLy-
cium fruits (Fructus Lycii). Plant Foods Hum. Nutr., 2005, 60,
161–164.
67. Potterat O., Goji (Lycium barbarum andLycium chinense): Phy-
tochemistry, pharmacology andsafety intheperspective oftradi-
tional uses andrecent popularity. Planta Med., 2010, 76, 7–19.
68. Reguła J., Gramza-Michałowska A., New cereal food products
with theaddition ofdried shiitake mushroom (Lentinula edodes) as
asource ofselected nutrients. Ital. J.Food Sci., 2010, 3, 292–297.
69. Reguła J., Gramza-Michałowska A., Nutritional value andglyce-
mic index ofcereal products with dried oyster mushroom (Pleu-
rotus ostreatus) added. Żywność. Nauka, Technologia, Jakość,
2013, 5, 119 – 128.
70. Rivera C.A., Ferro C.L., Bursua A.J., Gerber B.S., Probable inter-
action between Lycium barbarum (Goji) andwarfarin. Pharma-
cotherapy, 2012, 32, e50-e53.
71. Saldanha G.L., Summary of
comments received inresponse to
theFederal Register notice defi ning bioactive food components.
Federal Register, 2004, 69, 55821–55822.
72. Shan X., Zhou J, Ma T., Chai Q., Lycium barbarum polysaccha-
rides reduce exercise-induced oxidative stress. Int. J.Mol. Sci.,
2011, 12, 1081–1088.
73. Sharma R., Singh R.B., Bioactive foods andnutraceutical sup-
plementation criteria incardiovascular protection. Open Nutra-
ceut. J., 2010, 3, 141–153.
74. Shashirakhaa M.N., Mallikarjunaa S.E., Rajarathnama S.Status
ofbioactive compounds infoods, with focus on fruits andveg-
etables. Crit. Rev. Food Sci. Nutr., 2015, 55, 1324–1339.
75. Shen Z., Wang J., Li G., Effect ofextract ofLycium barbarum L.
on adult human retinal nerve cells. Chin. J.Ophthalmol., 2012,
48, 824–828.
76. Sidor A., Gramza-Michałowska A., Advanced research on
the antioxidant and health benefi t of elderberry (Sambucus
nigra) infood – areview. J.Funct. Foods, 2015, doi:10.1016/j.
jff2014.07.012, inpress.
77. Song M.K., Salam N.K., Roufogalis B.D., Huang T.H.W., Lycium
barbarum (Goji Berry) extracts andits taurine component inhibit
PPAR-γ-dependent gene transcription inhuman retinal pigment
epithelial cells: Possible implications for diabetic retinopathy
treatment. Biochem. Pharmacol., 2011, 82, 1209–1218.
78. Sopher L. Lauren. (n.d.)., Lycium barbarum L. climbers.lsa.
umich.edu, (11), 1–5. Retrieved from [http://climbers.lsa.umich.
edu/wpcontent/uploads/2013/07/LycibarbSOLAFINAL.pdf].
79. Srinath Reddy K., Katan M.B., Diet, nutrition andthepreven-
tion ofhypertension andcardiovascular diseases. Public Health
Nutr., 2004, 7, 167- 186.
80. Tang L., Zhang Y., Jiang Y., Willard L., Ortiz E., Wark L., Me-
deiros D., Lin D., Dietary wolfberry ameliorates retinal structure
abnormalities indb/db mice at the
early stage ofdiabetes. Exp.
Biol. Med., 2011, 236, 1051–1063.
81. Tang W.M., Chan E., Kwok C.Y., Lee Y.K., Wu J.H., Wan C.W.,
Chan S.W., Areview oftheanticancer andimmunomodulatory
effects ofLycium barbarum fruit. Infl ammopharmacology, 2012,
20, 307–314.
82. USDA, U.S.Department ofAgriculture, Agricultural Research
Service. 2010. Oxygen Radical Absorbance Capacity (ORAC)
ofSelected Foods, Release 2. Nutrient Data Laboratory Home
Page: http://www.ars.usda.gov/nutrientdata/orac
83. Wang C.C., Chang S.C., Inbaraj B.S., Chen B.H., Isolation
of carotenoids, fl avonoids and polysaccharides from Lycium
barbarum L. andevaluation ofantioxidant activity. Food Chem.,
2010, 120, 184–192.
84. Wu S., Ng L., Lin C., Antioxidant activities ofsome common in-
gredients oftraditional Chinese medicine, Angelica sinensis, Lycium
barbarum andPoria cocos. Phytother. Res., 2004, 18, 1008–1012.
85. Xiao J., Liong E., Ching Y., Chang R., Lycium barbarum poly-
saccharides protect mice liver from carbon tetrachloride-induced
oxidative stress and necroinfl ammation. J. Ethnopharmacol.,
2012, 139, 462–470.
86. Yu H., Wark L., Ji H., Willard L., Jaing Y., Han J., Lin D., Dietary
wolfberry upregulates carotenoid metabolic genes andenhances
mitochondrial biogenesis in the retina of db/db diabetic mice.
Mol. Nutr. Food Res., 2013, 57, 1158–1169.
87. Zhang M., Chen H., Huang J., Li Z., Zhu C., Zhang S., Ef-
fect of Lycium barbarum polysaccharide on human hepa-
toma QGY7703cells: inhibition ofproliferation andinduction
ofapoptosis. Life Sci., 2005, 76, 2115–2124.
88. Zhang Z., Liu X., Wu T., Liu J., Zhang X., Yang X., Wang Y.,
Selective suppression of
cervical cancer Hela cells by2-O-β-D-
glucopyranosyl-L-ascorbic acid isolated from thefruit ofLycium
barbarum L.Cell Biol. Toxicol., 2011a, 27, 107–121.
B.Kulczyński & A.Gramza-Michałowska 0
89. Zhang Z., Liu X., Zhang X., Liu J., Hao Y., Comparative evalu-
ation oftheantioxidant effects ofthenatural vitamin C analog
2-O-β-D-glucopyranosyl-L-ascorbic acid isolated from Goji
berry fruit. Arch. Pharm. Res., 2011b, 34, 801–810.
90. Zhao R., Li Q., Xiao B., Effect ofLycium barbarum polysaccha-
ride on theimprovement ofinsulin resistance inNIDDM rats.
Yakugaku zasshi.J.Pharmaceut. Soc. Jap., 2005, 125, 981–988.
91. Zhong Y., Shahidi F., Naczk M., Phytochemicals and health
benefi ts ofgoji berries. 2013, in: Dried Fruits: Phytochemicals
andHealth Effects, 1
st
Edition (eds. C.Alasalvar, F.Shahidi).
Wiley-Blackwell Publisher, Hoboken, New Jersey, pp. 133–144.
92. Zhu C.P., Zhang S.H., Lycium barbarum polysaccharide inhib-
its theproliferation ofHeLa cells byinducing apoptosis. J.Sci.
Food. Agric., 2013, 93, 149–156.
Submitted: 3February 2015. Revised: 4May and31May 2015.
Accepted: 3June 2015. Published on-line: 1March 2016.